glp-1 weight loss treatments How medications are transforming diabetes and treatment GLP-1 medications for weight loss

Circana compared purchase activity among GLP-1 weight loss user households compared to that of non-GLP-1 user households using a monthly per-household consumption index

Table 3 The specific clinical characteristics of GLP-1RA induced acute renal injury were excavated from FAERS

In most cases, you can have either an HSA or an FSA but not both simultaneously

And in 2025, Wegovy also received FDA accelerated approval for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, underscoring that these medications can impact disease processes well beyond body weight alone